SMARCA4 and neoplasm: As an example, SMARCA4 loss accelerates tumor progression and promotes lung adenocarcinoma (LUAD) dedifferentiation [15], while abrogation of another key SWI/SNF component, Arid1a, suppresses tumor initiation and metastasis in hepatocellular carcinoma [16].